Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 6,515 | 3,325 | 1,677 | 0 | 0 |
| Cost of Goods | 331 | 148 | 95 | N/A | N/A |
| Gross Profit | 6,184 | 3,177 | 1,582 | N/A | N/A |
| Operating Expenses | 7,532 | 7,991 | 6,947 | 7,670 | 7,899 |
| Operating Income | -1,017 | -4,666 | -5,270 | -6,135 | -7,899 |
| Interest Expense | 856 | 825 | 798 | 744 | 119 |
| Other Income | 6 | 47 | 16 | 31 | -71 |
| Pre-tax Income | -1,867 | -5,444 | -6,052 | -6,848 | -8,089 |
| Net Income Continuous | -1,867 | -5,444 | -6,052 | -6,848 | -8,089 |
| Net Income | $-1,867 | $-5,444 | $-6,052 | $-6,848 | $-8,089 |
| EPS Basic Total Ops | -0.07 | -0.21 | -0.23 | -0.26 | -0.31 |
| EPS Basic Continuous Ops | -0.07 | -0.21 | -0.23 | -0.26 | -0.31 |
| EPS Diluted Total Ops | -0.07 | -0.21 | -0.23 | -0.26 | -0.31 |
| EPS Diluted Continuous Ops | -0.07 | -0.21 | -0.23 | -0.26 | -0.31 |
| EBITDA(a) | $-945 | $-4,593 | $-5,198 | $-7,600 | $-7,835 |